{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:15:14Z","timestamp":1740107714651,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T00:00:00Z","timestamp":1541635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s10067-018-4350-5","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T17:29:57Z","timestamp":1541698197000},"page":"251-256","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Should a patient with rheumatoid arthritis be a kidney donor?"],"prefix":"10.1007","volume":"38","author":[{"given":"Richard","family":"Seto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren M.","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5467-2257","authenticated-orcid":false,"given":"Richard S.","family":"Panush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,8]]},"reference":[{"issue":"2","key":"4350_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1053\/j.ajkd.2013.08.010","volume":"63","author":"LJ Hickson","year":"2014","unstructured":"Hickson LJ, Crowson C, Gabriel SE, McCarthy JT, Matteson EL (2014) Development of reduced kidney function in rheumatoid arthritis. Am J Kidney Dis 63(2):206\u2013213. https:\/\/doi.org\/10.1053\/j.ajkd.2013.08.010","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"4350_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4081\/reumatismo.2003.76","volume":"55","author":"A Icardi","year":"2003","unstructured":"Icardi A, Araghi P, Ciabattoni M, Romano U, Lazzarini P, Bianchi G (2003) Kidney involvement in rheumatoid arthritis. Reumatismo 55(2):76\u201385. https:\/\/doi.org\/10.4081\/reumatismo.2003.76","journal-title":"Reumatismo"},{"issue":"9","key":"4350_CR3","doi-asserted-by":"publisher","first-page":"e0136508","DOI":"10.1371\/journal.pone.0136508","volume":"10","author":"H-Y Chiu","year":"2015","unstructured":"Chiu H-Y, Huang H-L, Li C-H, Chen H-A, Yeh C-L, Chiu S-H, Ho S-Y (2015) Increased risk of chronic kidney disease in rheumatoid arthritis associated with cardiovascular complications \u2013 a national population-based cohort study. PLoS One 10(9):e0136508. https:\/\/doi.org\/10.1371\/journal.pone.0136508","journal-title":"PLoS One"},{"issue":"2","key":"4350_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/cphy.c120028","volume":"3","author":"JD Imig","year":"2013","unstructured":"Imig JD, Ryan MJ (2013) Immune and inflammatory role in renal disease. Compr Physiol 3(2):957\u2013976. https:\/\/doi.org\/10.1002\/cphy.c120028","journal-title":"Compr Physiol"},{"issue":"8","key":"4350_CR5","doi-asserted-by":"publisher","first-page":"e0160225","DOI":"10.1371\/journal.pone.0160225","volume":"11","author":"M Kochi","year":"2016","unstructured":"Kochi M, Kohagura K, Shiohira Y, Iseki K, Ohya Y (2016) Inflammation as a risk of developing chronic kidney disease in rheumatoid arthritis. PLoS One 11(8):e0160225. https:\/\/doi.org\/10.1371\/journal.pone.0160225","journal-title":"PLoS One"},{"issue":"3","key":"4350_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.12861\/jrip.2015.12","volume":"4","author":"H Ghane Shahrbaf","year":"2015","unstructured":"Ghane Shahrbaf H, Assadi F (2015) Drug-induced renal disorders. J Renal Inj Prev 4(3):57\u201360. https:\/\/doi.org\/10.12861\/jrip.2015.12","journal-title":"J Renal Inj Prev"},{"key":"4350_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/art.1780380213","volume":"38","author":"HJ Helin","year":"1995","unstructured":"Helin HJ, Korpela MM, Mustonen JT, Pasternack AI (1995) Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum 38:242\u2013247. https:\/\/doi.org\/10.1002\/art.1780380213","journal-title":"Arthritis Rheum"},{"key":"4350_CR8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/acr.22713","volume":"68","author":"M Couderc","year":"2016","unstructured":"Couderc M, Tatar Z, Pereira B, Tiple A, Gilson M, Fautrel B, Pouplin S, Dernis E, Gossec L, Gaujoux-Viala C, Soubrier M, Dougados M (2016) Prevalence of renal impairment in patients with rheumatoid arthritis: results from a cross-sectional multicenter study. Arthritis Care Res 68:638\u2013644. https:\/\/doi.org\/10.1002\/acr.22713","journal-title":"Arthritis Care Res"},{"issue":"4","key":"4350_CR9","doi-asserted-by":"publisher","first-page":"R116","DOI":"10.1186\/ar2775","volume":"11","author":"D Daoussis","year":"2009","unstructured":"Daoussis D, Panoulas V, Toms T, Antonopoulos JH, Nightingale P, Kitas GD (2009) Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis. Arthritis Res Ther 11(4):R116. https:\/\/doi.org\/10.1186\/ar2775","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"4350_CR10","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/rheumatology\/36.11.1189","volume":"36","author":"M Korpela","year":"1997","unstructured":"Korpela M, Mustonen J, Teppo AM, Helin H, Pasternack A (1997) Mesangial glomerulonephritis as an extra-articular manifestation of rheumatoid arthritis. Br J Rheumatol 36(11):1189\u20131195","journal-title":"Br J Rheumatol"},{"issue":"4","key":"4350_CR11","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/ph3041279","volume":"3","author":"M Dixit","year":"2010","unstructured":"Dixit M, Doan T, Kirschner R, Dixit N (2010) Significant acute kidney injury due to non-steroidal anti-inflammatory drugs: inpatient setting. Pharmaceuticals 3(4):1279\u20131285. https:\/\/doi.org\/10.3390\/ph3041279","journal-title":"Pharmaceuticals"},{"issue":"3","key":"4350_CR12","doi-asserted-by":"publisher","first-page":"280.e1","DOI":"10.1016\/j.amjmed.2006.02.015","volume":"120","author":"K Gooch","year":"2007","unstructured":"Gooch K, Culleton BF, Manns BJ, Zhang J, Alfonso H, Tonelli M, Frank C, Klarenbach S, Hemmelgarn BR (2007) NSAID use and progression of chronic kidney disease. Am J Med 120(3):280.e1\u2013280.e7. https:\/\/doi.org\/10.1016\/j.amjmed.2006.02.015","journal-title":"Am J Med"},{"key":"4350_CR13","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1136\/annrheumdis-2013-204078","volume":"74","author":"B M\u00f6ller","year":"2015","unstructured":"M\u00f6ller B, Pruijm M, Adler S, on behalf of the Swiss Clinical Quality Management in Rheumatic Diseases (SCQM) Foundation, CH-8048 Zurich, Switzerland, Scherer A, Villiger PM, Finckh A (2015) Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study. Ann Rheum Dis 74:718\u2013723","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4350_CR14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.18553\/jmcp.2012.18.3.234","volume":"18","author":"M Kelkar","year":"2012","unstructured":"Kelkar M, Cleves MA, Foster HR, Hogan WR, James LP, Martin BC (2012) Acute and chronic acetaminophen use and renal disease: a case-control study using pharmacy and medical claims. J Manag Care Pharm 18(3):234\u2013246","journal-title":"J Manag Care Pharm"},{"issue":"3","key":"4350_CR15","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1053\/sarh.2000.16641","volume":"30","author":"MH Schiff","year":"2000","unstructured":"Schiff MH, Whelton A (2000) Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis. Semin Arthritis Rheum 30(3):196\u2013208. https:\/\/doi.org\/10.1053\/sarh.2000.16641","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"4350_CR16","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1172\/JCI116440","volume":"91","author":"DM Lanese","year":"1993","unstructured":"Lanese DM, Conger JD (1993) Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 91(5):2144\u20132149","journal-title":"J Clin Invest"},{"issue":"2","key":"4350_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.autrev.2008.05.001","volume":"8","author":"R Caporali","year":"2008","unstructured":"Caporali R, Caprioli M, Bobbio-Pallavicini F, Montecucco C (2008) DMARDS and infections in rheumatoid arthritis. Autoimmun Rev 8(2):139\u2013143. https:\/\/doi.org\/10.1016\/j.autrev.2008.05.001","journal-title":"Autoimmun Rev"},{"issue":"6","key":"4350_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.semarthrit.2015.01.008","volume":"44","author":"SM Goodman","year":"2015","unstructured":"Goodman SM (2015) Rheumatoid arthritis: perioperative management of biologics and DMARDs. Semin Arthritis Rheum 44(6):627\u2013632. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.01.008","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"4350_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5312\/wjo.v5.i3.283","volume":"5","author":"ML Krause","year":"2014","unstructured":"Krause ML, Matteson EL (2014) Perioperative management of the patient with rheumatoid arthritis. World J Orthop 5(3):283\u2013291. https:\/\/doi.org\/10.5312\/wjo.v5.i3.283","journal-title":"World J Orthop"},{"issue":"5","key":"4350_CR20","first-page":"856","volume":"27","author":"E Loza","year":"2009","unstructured":"Loza E, Martinez-Lopez JA, Carmona L (2009) A systematic review on the optimum management of the use of methotrexate in rheumatoid arthritis patients in the perioperative period to minimize perioperative morbidity and maintain disease control. Clin Exp Rheumatol 27(5):856\u2013862","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"4350_CR21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.semarthrit.2006.10.003","volume":"36","author":"H Pieringer","year":"2007","unstructured":"Pieringer H, Stuby U, Biesenbach G (2007) Patients with rheumatoid arthritis undergoing surgery: how should we deal with antirheumatic treatment? Semin Arthritis Rheum 36(5):278\u2013286 Review","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"4350_CR22","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1016\/j.arth.2017.05.001","volume":"32","author":"B Springer","year":"2017","unstructured":"Goodman SM, Springer B, Guyatt G (2017) 2017 American College of Rheumatology\/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. J Arthroplast 32(9):2628\u20132638. https:\/\/doi.org\/10.1016\/j.arth.2017.05.001","journal-title":"J Arthroplast"},{"issue":"4","key":"4350_CR23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.7182\/pit2015229","volume":"25","author":"W Cheungpasitporn","year":"2015","unstructured":"Cheungpasitporn W, Thongprayoon C, Ungprasert P, Erickson SB (2015) Outcomes of living kidney donors with rheumatoid arthritis. Prog Transplant 25(4):307\u2013310. https:\/\/doi.org\/10.7182\/pit2015229","journal-title":"Prog Transplant"},{"key":"4350_CR24","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/acr.23016","volume":"69","author":"P Hamann","year":"2017","unstructured":"Hamann P, Holland R, Hyrich K (2017) Factors associated with sustained remission in rheumatoid arthritis in patients treated with anti-tumor necrosis factor. Arthritis Care Res 69:783\u2013793. https:\/\/doi.org\/10.1002\/acr.23016","journal-title":"Arthritis Care Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4350-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4350-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4350-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T16:40:13Z","timestamp":1662396013000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4350-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,8]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["4350"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4350-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2018,11,8]]},"assertion":[{"value":"1 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}